Jeffrey M. Goldberg
2022
In 2022, Jeffrey M. Goldberg earned a total compensation of $1.8M as President and Chief Executive Officer at Aeglea BioTherapeutics.
Compensation breakdown
| Option Awards | $1,774,952 |
|---|---|
| Salary | $54,616 |
| Other | $2,917 |
| Total | $1,832,485 |
Goldberg received $1.8M in option awards, accounting for 97% of the total pay in 2022.
Goldberg also received $54.6K in salary and $2.9K in other compensation.
Rankings
In 2022, Jeffrey M. Goldberg's compensation ranked 1,876th out of 5,542 executives tracked by ExecPay. In other words, Goldberg earned more than 66.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,876 out of 5,542 | 66th |
Division Manufacturing | 986 out of 3,000 | 67th |
Major group Chemicals And Allied Products | 411 out of 1,350 | 70th |
Industry group Drugs | 376 out of 1,253 | 70th |
Industry Pharmaceutical Preparations | 268 out of 907 | 71st |
Source: SEC filing on October 26, 2023.
Goldberg's colleagues
We found four more compensation records of executives who worked with Jeffrey M. Goldberg at Aeglea BioTherapeutics in 2022.